Program - Society of Toxicology
Program - Society of Toxicology
Program - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Society</strong> <strong>of</strong> <strong>Toxicology</strong> 2011<br />
Continuing Education (Continued)<br />
Today toxicologists must select appropriate model organisms, manage<br />
abundant high-throughput data, understand legacy data, and develop<br />
pathway-based understanding <strong>of</strong> environmental factors influencing<br />
biological systems. Mastery <strong>of</strong> these concepts improves toxicity prediction<br />
while providing insights into environmentally influenced diseases<br />
and phenotypes. A clear understanding <strong>of</strong> the diverse on-line data resource<br />
aims and limitations equips the researcher with the best combination <strong>of</strong><br />
resources to effectively address their questions.<br />
• Reactome Knowledgebase, Marc E. Gillespie, St. Johns University,<br />
Jamaica, NY<br />
• Comparative Toxicogenomics Database (CTD), Carolyn J.<br />
Mattingly, Mount Desert Island Biological Laboratory, Salisbury Cove,<br />
ME<br />
• PharmGKB, Teri E. Klein and Li Gong, Stanford University Medical<br />
Center, Stanford, CA<br />
• Mouse Genome Informatics Database, Susan M. Bello, Jackson<br />
Laboratory, Bar Harbor, ME<br />
Sunday Morning, March 6<br />
8:15 AM to 12:00 NOON<br />
First and Second Level (See signage at CE Booths for room<br />
locations)<br />
Epigenetic Mechanisms<br />
Epigenetics in <strong>Toxicology</strong>: Introduction, Mechanistic<br />
Understanding, and Applications in Safety Assessment<br />
AM05<br />
CE Basic<br />
Chairperson(s): Mayurranjan S. Mitra, Washington University School <strong>of</strong><br />
Medicine, St. Louis, MO, and Thomas Sussan, Johns Hopkins University<br />
Bloomberg School <strong>of</strong> Public Health, Baltimore, MD.<br />
Sponsor:<br />
Molecular Biology Specialty Section<br />
Endorsed by:<br />
Carcinogenesis Specialty Section<br />
Cardiovascular <strong>Toxicology</strong> Specialty Section<br />
Mechanisms Specialty Section<br />
Epigenetics refers to molecular mechanisms that cause heritable changes<br />
in gene expression without altering the DNA sequence. The most<br />
widely studied epigenetic mechanisms encompass DNA methylation,<br />
histone modifications, and gene regulation by non-coding RNAs, such<br />
as microRNAs. Typically, these mechanisms are required for normal<br />
cellular development and differentiation; however, perturbations in<br />
them can lead to diseases, notably cancer. Increasing evidence suggest<br />
that environmental factors such as diet, stress, and exposure to radiation<br />
and xenobiotics can induce heritable changes in the epigenetic status,<br />
potentially affecting the health <strong>of</strong> the present and future generations.<br />
Importantly, the long-term and life-threatening consequences <strong>of</strong> environment/chemical-induced<br />
changes in epigenetics, makes this field a critical<br />
area for future exploration by toxicologists. The course will begin by<br />
introducing the fundamental concepts <strong>of</strong> epigenetics and reviewing the<br />
various underlying mechanisms. Methods to assess epigenetic changes<br />
will be discussed, followed by a discussion <strong>of</strong> the role <strong>of</strong> DNA cytosine<br />
methylation in the regulation <strong>of</strong> carcinogen-inducible CYP450 genes.<br />
Mechanistic understanding <strong>of</strong> the role <strong>of</strong> microRNAs in the regulation<br />
<strong>of</strong> cellular toxicity and the influence <strong>of</strong> environment on epigenetics that<br />
cause developmental effects will also be presented. Finally, the future <strong>of</strong><br />
epigenetics in toxicology and its potential applications for safety assessment<br />
will be discussed. Students as well as toxicologists working in<br />
academia, federal and pharmaceutical industries, and researchers interested<br />
in mechanistic toxicology will benefit from taking this course.<br />
• Introduction, Mayurranjan S. Mitra, Washington University School <strong>of</strong><br />
Medicine, St. Louis, MO<br />
• Introduction and Overview <strong>of</strong> Epigenetics, James G. Herman, The<br />
Johns Hopkins School <strong>of</strong> Medicine, Baltimore, MD<br />
• Role <strong>of</strong> Epigenetics in the Regulation <strong>of</strong> Carcinogen-Metabolizing<br />
Enzymes, Oliver Hankinson, University <strong>of</strong> California Los Angeles,<br />
Los Angeles, CA<br />
• Retroelements and MicroRNAs in the Epigenetic Regulation <strong>of</strong><br />
Cellular Differentiation, Proliferation, and Toxicity, Kenneth S.<br />
Ramos, University <strong>of</strong> Louisville, Louisville, KY<br />
• Epigenetic Gene Regulation: Linking Early Developmental<br />
Environment to Adult Disease, Dana Dolinoy, University <strong>of</strong><br />
Michigan, Ann Arbor, MI<br />
• What We Need to Know Prior to Incorporating an Epigenetic<br />
Evaluation into Safety Assessments, Jay I. Goodman, Michigan State<br />
University, East Lansing, MI<br />
Sunday Morning, March 6<br />
8:15 AM to 12:00 NOON<br />
First and Second Level (See signage at CE Booths for room<br />
locations)<br />
Integration <strong>of</strong> Toxicological and Epidemiological Evidence<br />
to Understand Human Risk<br />
Protecting Human Health: Use <strong>of</strong> Toxicological and<br />
Epidemiological Data in Determining Safe Levels for Human<br />
Exposure<br />
AM06<br />
CE Basic<br />
Chairperson(s): Eileen P. Hayes, EP Hayes <strong>Toxicology</strong> Services LLC,<br />
Longmont, CO, and Terry Gordon, New York University School <strong>of</strong><br />
Medicine, Tuxedo Park, NY.<br />
Sponsor:<br />
Occupational and Public Health Specialty Section<br />
Toxicological and epidemiological data are the basis for risk assessment<br />
processes used to determine acceptable levels <strong>of</strong> exposure. This is the<br />
case for the general public who may be exposed to pollutants via ambient<br />
air and/or drinking water, for workers who may be exposed to chemicals<br />
in the workplace, and for patients who may have exposure to both active<br />
pharmaceutical ingredients (API) and impurities that may be present in<br />
the product. The goal <strong>of</strong> this course is to provide students with an understanding<br />
<strong>of</strong> the regulatory background and the practical application <strong>of</strong><br />
both toxicological and epidemiological information in setting exposure<br />
levels considered to be protective <strong>of</strong> public health. The objectives <strong>of</strong> this<br />
course are 1) to describe the regulatory requirements that underlie development<br />
<strong>of</strong> acceptable levels <strong>of</strong> exposure for either the general population<br />
or select populations (workers, patients) via the media described above;<br />
and 2) to describe the evaluation <strong>of</strong> toxicological and epidemiological<br />
data in determining acceptable levels <strong>of</strong> exposure. Case studies <strong>of</strong> representative<br />
compounds will illustrate the processes. The U.S. Environmental<br />
Protection Agency (U.S. EPA) has well-defined processes for establishing<br />
both National Ambient Air Quality Standards (NAAQS) under the Clean<br />
Air Act and drinking water Maximum Contaminant Levels (MCLs) under<br />
the Safe Drinking Water Act. The Occupational Health and Safety Administration<br />
(OSHA) promulgates permissible exposure limits (PELs) for the<br />
workplace. The American Conference <strong>of</strong> Government Industrial Hygienists<br />
(ACGIH), a nonpr<strong>of</strong>it, non-governmental organization publishes<br />
Threshold Limit Values (TLVs) that are used globally by many public and<br />
private-sector employers to protect the health <strong>of</strong> their employees. Additionally,<br />
many employers have established programs to derive acceptable<br />
levels <strong>of</strong> workplace exposure for compounds not specifically regulated<br />
by government agencies. Acceptable identification, reporting, and safety<br />
thresholds for impurities in drug products are governed under guidance<br />
CE<br />
up-to-date information at www.toxicology.org<br />
91